Northeast Investment Management Medtronic PLC Transaction History

Northeast Investment Management

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$76.72 - $87.58 $30,534 - $34,856	-398 Reduced 11.85%	2,961 $238,000
Q4 2022 Jan 27, 2023	BUY	$76.18 - $87.74 $3,656 - $4,211	48 Added 1.45%	3,359 $261,000
Q3 2022 Oct 28, 2022	SELL	$80.75 - $95.31 $38,760 - $45,748	-480 Reduced 12.66%	3,311 $267,000
Q1 2022 May 04, 2022	BUY	$100.58 - $112.38 $35,001 - $39,108	348 Added 10.11%	3,791 $421,000
Q4 2021 Feb 07, 2022	SELL	$99.53 - $127.75 $27,171 - $34,875	-273 Reduced 7.35%	3,443 $356,000
Q3 2021 Nov 08, 2021	BUY	$122.75 - $135.17 $69,231 - $76,235	564 Added 17.89%	3,716 $466,000
Q1 2021 May 11, 2021	SELL	$111.18 - $119.74 $33,131 - $35,682	-298 Reduced 8.64%	3,152 $372,000
Q3 2020 Nov 13, 2020	SELL	$90.13 - $108.78 $40,017 - $48,298	-444 Reduced 11.4%	3,450 $359,000
Q2 2020 Aug 11, 2020	SELL	$84.11 - $103.33 $49,624 - $60,964	-590 Reduced 13.16%	3,894 $357,000
Q1 2020 May 13, 2020	SELL	$72.92 - $121.3 $321,212 - $534,326	-4,405 Reduced 49.56%	4,484 $404,000
Q4 2019 Feb 12, 2020	SELL	$104.49 - $114.54 $1,671 - $1,832	-16 Reduced 0.18%	8,889 $1.01 Million
Q3 2019 Nov 13, 2019	BUY	$98.02 - $111.18 $165,163 - $187,338	1,685 Added 23.34%	8,905 $967,000
Q2 2019 Aug 12, 2019	BUY	$84.15 - $99.38 $63,954 - $75,528	760 Added 11.76%	7,220 $703,000
Q1 2019 May 14, 2019	SELL	$82.45 - $93.79 $6,266 - $7,128	-76 Reduced 1.16%	6,460 $588,000
Q4 2017 Jan 29, 2018	SELL	$76.93 - $83.5 $2,692 - $2,922	-35 Reduced 0.53%	6,536 $528,000
Q3 2017 Nov 13, 2017	BUY	$77.71 - $84.6 $510,632 - $555,906	6,571	6,571 $511,000

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $114B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

Stay updated on Northeast Investment Management with notifications on news.